Devi Jeyachandran, MD - Medicare Pathology in Buffalo, NY

Devi Jeyachandran, MD is a medicare enrolled "Pathology - Anatomic Pathology" physician in Buffalo, New York. She graduated from medical school in 2007 and has 17 years of diverse experience with area of expertise as Pathology. She is a member of the group practice Morristown Pathology Associates Pa and her current practice location is Elm And Carlton St, Buffalo, New York. You can reach out to her office (for appointments etc.) via phone at (716) 845-2300.

Devi Jeyachandran is licensed to practice in New Jersey (license number 25MA11731000) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1184043960.

Contact Information

Devi Jeyachandran, MD
Elm And Carlton St,
Buffalo, NY 14263-6504
(716) 845-2300
Not Available



Physician's Profile

Full NameDevi Jeyachandran
GenderFemale
SpecialityPathology
Experience17 Years
LocationElm And Carlton St, Buffalo, New York
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Devi Jeyachandran graduated from medical school in 2007
  NPI Data:
  • NPI Number: 1184043960
  • Provider Enumeration Date: 04/09/2014
  • Last Update Date: 07/25/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 8022357862
  • Enrollment ID: I20230817000652

Medical Identifiers

Medical identifiers for Devi Jeyachandran such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1184043960NPI-NPPES
296677OtherNYNYS LICENSE

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207ZP0101XPathology - Anatomic Pathology 296677 (New York)Secondary
207ZP0101XPathology - Anatomic Pathology 25MA11731000 (New Jersey)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Overlook Medical CenterSummit, NJHospital
Morristown Medical CenterMorristown, NJHospital
Chilton Medical CenterPompton plains, NJHospital
Newton Medical CenterNewton, NJHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Morristown Pathology Associates Pa498169971729

News Archive

Bayer and Onyx announce Phase 3 trial evaluating use of NEXAVAR for patients with HCC after local ablation

Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.

Study explores safety and efficacy of scoop and run approach in Philadelphia

A new study from the Perelman School of Medicine at the University of Pennsylvania has found no significant difference in adjusted overall survival rates between gunshot and stabbing (so-called penetrating trauma injuries) victims in Philadelphia whether they were transported to the emergency department by the police department or the emergency medical services division of the fire department.

New exhibit highlights global health work of Seattle-area institutions

An exhibit highlighting the global health work of Seattle-area institutions is opening Tuesday in the Next 50 Plaza at Seattle Center, the Seattle Times reports.

New co-branded Medicare Part D prescription drug plan from Humana and Walmart

Today, Humana Inc. announced an innovative Medicare Part D prescription drug plan, co-branded with Wal-Mart Stores, Inc., that can provide significant savings on monthly plan premiums and prescription medicine copayments and cost-shares for Medicare beneficiaries, including seniors and people with disabilities.

Whole parasite malaria vaccine to be manufactured for clinical trials

Sanaria Inc. and the PATH Malaria Vaccine Initiative has officially opened a one-of-a-kind clinical manufacturing facility to produce a vaccine that uses a weakened form of the malaria parasite to fight a disease that annually kills more than one million people, most of them African children.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Devi Jeyachandran allows following entities to bill medicare on her behalf.
Entity NameMorristown Pathology Associates Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1922075886
PECOS PAC ID: 4981699717
Enrollment ID: O20040420000045

News Archive

Bayer and Onyx announce Phase 3 trial evaluating use of NEXAVAR for patients with HCC after local ablation

Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.

Study explores safety and efficacy of scoop and run approach in Philadelphia

A new study from the Perelman School of Medicine at the University of Pennsylvania has found no significant difference in adjusted overall survival rates between gunshot and stabbing (so-called penetrating trauma injuries) victims in Philadelphia whether they were transported to the emergency department by the police department or the emergency medical services division of the fire department.

New exhibit highlights global health work of Seattle-area institutions

An exhibit highlighting the global health work of Seattle-area institutions is opening Tuesday in the Next 50 Plaza at Seattle Center, the Seattle Times reports.

New co-branded Medicare Part D prescription drug plan from Humana and Walmart

Today, Humana Inc. announced an innovative Medicare Part D prescription drug plan, co-branded with Wal-Mart Stores, Inc., that can provide significant savings on monthly plan premiums and prescription medicine copayments and cost-shares for Medicare beneficiaries, including seniors and people with disabilities.

Whole parasite malaria vaccine to be manufactured for clinical trials

Sanaria Inc. and the PATH Malaria Vaccine Initiative has officially opened a one-of-a-kind clinical manufacturing facility to produce a vaccine that uses a weakened form of the malaria parasite to fight a disease that annually kills more than one million people, most of them African children.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Devi Jeyachandran is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Devi Jeyachandran, MD
P.o. Box 500,
Hackettstown, NJ 07840

Ph: (212) 241-8014
Devi Jeyachandran, MD
Elm And Carlton St,
Buffalo, NY 14263-6504

Ph: (716) 845-2300

News Archive

Bayer and Onyx announce Phase 3 trial evaluating use of NEXAVAR for patients with HCC after local ablation

Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.

Study explores safety and efficacy of scoop and run approach in Philadelphia

A new study from the Perelman School of Medicine at the University of Pennsylvania has found no significant difference in adjusted overall survival rates between gunshot and stabbing (so-called penetrating trauma injuries) victims in Philadelphia whether they were transported to the emergency department by the police department or the emergency medical services division of the fire department.

New exhibit highlights global health work of Seattle-area institutions

An exhibit highlighting the global health work of Seattle-area institutions is opening Tuesday in the Next 50 Plaza at Seattle Center, the Seattle Times reports.

New co-branded Medicare Part D prescription drug plan from Humana and Walmart

Today, Humana Inc. announced an innovative Medicare Part D prescription drug plan, co-branded with Wal-Mart Stores, Inc., that can provide significant savings on monthly plan premiums and prescription medicine copayments and cost-shares for Medicare beneficiaries, including seniors and people with disabilities.

Whole parasite malaria vaccine to be manufactured for clinical trials

Sanaria Inc. and the PATH Malaria Vaccine Initiative has officially opened a one-of-a-kind clinical manufacturing facility to produce a vaccine that uses a weakened form of the malaria parasite to fight a disease that annually kills more than one million people, most of them African children.

Read more News

› Verified 6 days ago


Pathology Doctors in Buffalo, NY

Young T Zhou, MD
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 2605 Harlem Rd, Buffalo, NY 14225
Phone: 716-891-2715    Fax: 716-529-3992
Dr. Zhongbo Yang, M.D.
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: Elm And Carlton Streets, Buffalo, NY 14263
Phone: 716-845-2300    
Dr. Daniel Amsterdam, PHD
Pathology
Medicare: Not Enrolled in Medicare
Practice Location: 462 Grinder St, Erie County Medical Center, Buffalo, NY 14215
Phone: 716-898-3114    Fax: 716-898-3090
Yousef Soofi, MD
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 100 High St, Buffalo, NY 14203
Phone: 716-859-2259    
Dr. Leorosa Orendain Lehman, M.D.
Pathology
Medicare: Not Enrolled in Medicare
Practice Location: 462 Grider St, Room L-169a, Buffalo, NY 14215
Phone: 716-898-3451    Fax: 716-898-4049
Fadi Habib, MD
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: Elm And Carlton St, Buffalo, NY 14263
Phone: 716-845-2300    Fax: 716-845-3427
Saraswati Pokharel, MD
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: Elm And Carlton Streets, Buffalo, NY 14263
Phone: 716-845-2300    Fax: 716-845-3427

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.